ISMPP 2025-Voice of Patients, Patient Voice

“Voice of Patient” in Publications: Trends and Perspectives

This page contains a poster presented at the 21st Annual Meeting of ISMPP (International Society for Medical Publication Professionals), which took place May 12-14, 2025. Authors and affiliations Authors: Swapna Ganduri, Jeenu Jacob, Ruchika Agrawal, Nilima Vyas, Charvin D'souza, and Namita Bose Affiliation: Cactus Life Sciences, Mumbai, India Abstract Objective: Power of the patient voice can significantly improve patients’…...
Read More

Top Stories

DIA MASC 2025

Medical Affairs 2.0: GenAI as the Catalyst for

Digital and AI were hot topics underpinning many of the...
Biopharma 2025 Trends

Biopharma Trends 2025: 3 Things to Know Right Now

The global business climate is ever-evolving, and 2025 looks...

The Paradigm Shift from Traditional Scientific

In the rapidly evolving biopharma landscape, the approach to...
Vaccine

Role of Scientific Communication and Medical Professionals in Combating Vaccine Hesitancy

Read an insightful discussion from the latest ISMPP conference on how science communication and medical...
ISMPP full report image

17th Virtual Annual Meeting of ISMPP: A Summarized Report

Session summaries from the latest ISMPP conference on trust and equity in science, digital transformation...
Pexels Anna Shvets

How Academic Societies Are Embracing the New Digital World: A Look at the Years Gone by and Ahead

The pandemic has required traditional academic societies to rapidly pivot to digital formats for conferences...
Digital therapeutics and medical communications

Digital Therapeutics and Medical Communications: Are We Ready?

Digital Therapeutics are very new and complex, and their use will involve changing standard therapeutic...
Medical writing and communication during the COVID-19 crisis

Medical Writing and Medical Communication during COVID-19 Crisis: AMWA Virtual Event

How medical writers and science communicators are called to respond to the COVID-19 infodemic...

Learn more ABOUT our company.